
Sep 14, 2026
AstraZeneca’s AI Pathology Study Signals Next Wave in Cancer Diagnostics
AstraZeneca has provided an update on its clinical study examining the integration of AI and computational pathology in diagnosing suspected non-small cell lung cancer and breast cancer.The study, which is observational in nature, evaluates how pathologists utilize digital tools in real-world settings. By analyzing existing patient samples, the research aims to determine how AI can enhance diagnostic accuracy and efficiency, potentially influencing the demand for targeted cancer therapies and th

